The SSRIs: advantages, disadvantages and differences

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Journal of Psychopharmacology

• Publication date

  1995-03-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1177/0269881195009002011PMID 22297235
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The kinetics of citalopram: single and multiple dose studies in man.

  2009cited by this paper
• Pharmacokinetic pharmacodynamic evaluation of the combined administration of alprazolam and fluoxetine

  2005cited by this paper
• Comparative animal studies on cardiovascular toxicity of tri- and tetracyclic antidepressants and citalopram; relation to drug plasma levels

  2004cited by this paper
• Biochemical effects of the antidepressant paroxetine, a specific 5-hydroxytryptamine uptake inhibitor

  2004cited by this paper
• Fluvoxamine-tricyclic antidepressant interaction

  2004cited by this paper
• Why do some antidepressants promote suicide?

  2004cited by this paper
• Kinetics of citalopram in elderly patients

  2004cited by this paper
• Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology

  2004cited by this paper
• [Paroxetine in the treatment of premature ejaculation].

  1997cited by this paper
• Sertraline treatment for premature ejaculation.

  1995cited by this paper
• A double-blind, placebo-controlled trial of two dose ranges of nefazodone in the treatment of depressed outpatients.

  1995cited by this paper
• Are patients who are intolerant to one serotonin selective reuptake inhibitor intolerant to another?

  1995cited by this paper
• Sertraline in the treatment of social phobia.

  1995cited by this paper
• Withdrawal Phenomena Associated with Antidepressant and Antipsychotic Agents

  1994cited by this paper
• Prophylactic treatment of depression.

  1994cited by this paper
• Carbamazepine and sertraline.

  1994cited by this paper
• Validity of Maori ethnicity statistics.

  1994cited by this paper
• Pharmacokinetics of desipramine coadministered with sertraline or fluoxetine.

  1994cited by this paper
• PHARMACOTHERAPY OF THE DEPRESSED PATIENT WITH CARDIOVASCULAR AND/OR CEREBROVASCULAR ILLNESS

  1994cited by this paper
• Induction of Mania with Selective Serotonin Re-uptake Inhibitors and Tricyclic Antidepressants

  1994cited by this paper
• A meta-analysis of the efficacy of selective serotonin reuptake inhibitors compared to tricyclic antidepressants in depression

  1994cited by this paper
• Electrophysiological evidence that desmethylsertraline is inactive at blocking central 5-HT uptake in vivo

  1994cited by this paper
• Paroxetine treatment of premature ejaculation: a double-blind, randomized, placebo-controlled study.

  1994cited by this paper
• Pharmacotherapy for ‘pure’ dysthymia: setraline vs. imipramine and placebo

  1994cited by this paper
• Paroxetine in the elderly depressed patient: randomized comparison with fluoxetine of efficacy, cognitive and behavioural effects

  1994cited by this paper
• SSRIs in depressed elderly; a double-blind comparison of sertraline and fluoxetine in depressed geriatric outpatients

  1994cited by this paper
• Greater toxicity in overdose of dothiepin than of other tricyclic antidepressants.

  1994cited by this paper
• Reducing the economic burden of depression

  1994cited by this paper
• Selective serotonin reuptake inhibitors: meta‐analysis of discontinuation rates

  1994cited by this paper
• A double-blind comparison of paroxetine and fluvoxamine in major depression

  1993cited by this paper
• Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes.

  1993cited by this paper
• Alprazolam pharmacokinetics, metabolism, and plasma levels: clinical implications.

  1993cited by this paper
• Fluoxetine efficacy in social phobia.

  1993cited by this paper
• A comparison of paroxetine and placebo in depressed outpatients

  1993cited by this paper
• Obsessive compulsive disorder in children and adolescents: issues in management.

  1993cited by this paper
• Suicide in depressed patients: medico-legal issues.

  1993cited by this paper
• The importance of ECG monitoring in antidepressant treatment

  1993cited by this paper
• Fluoxetine-induced sexual dysfunction.

  1993cited by this paper
• Detectable levels of fluoxetine metabolites after discontinuation: an unexpected serotonin syndrome.

  1993cited by this paper
• Selective serotonin re-uptake inhibitors: use in depression

  1993cited by this paper
• The neuroanatomy of depression.

  1993cited by this paper
• Serotonin syndrome produced by a combination of fluoxetine and lithium.

  1993cited by this paper
• Sexual dysfunction during antidepressant treatment.

  1993cited by this paper
• Isozyme specific drug oxidation: Genetic polymorphism and drug-drug interactions

  1993cited by this paper
• Managing depression in general practice.

  1993cited by this paper
• Toxic serotonin syndrome after fluoxetine plus carbamazepine.

  1993cited by this paper
• Fluoxetine-warfarin interaction.

  1993cited by this paper
• A Double‐Blind, Randomized, Fluoxetine‐Controlled, Multicenter Study of Paroxetine in the Treatment of Depression

  1993cited by this paper
• A primary care perspective on management of acute and long-term depression.

  1993cited by this paper
• Antidepressant therapy in the physically ill: a therapeutic opportunity for the selective 5-HT re-uptake inhibitors?

  1993cited by this paper
• Clinical pharmacokinetics of selective serotonin reuptake inhibitors.

  1993cited by this paper
• Cyclobenzaprine-induced delirium in two octogenarians.

  1993cited by this paper
• Sertraline in the treatment of bulimia nervosa.

  1993cited by this paper
• Possible monoamine oxidase inhibitor-serotonin uptake inhibitor interaction: fluoxetine clinical data and preclinical findings.

  1993cited by this paper
• Titration of serotonin reuptake blockers.

  1993cited by this paper
• Five fatal cases of serotonin syndrome after moclobemide-citalopram or moclobemide-clomipramine overdoses.

  1993cited by this paper
• A randomized double-blind study of fluoxetine versus placebo in the treatment of dysthymia.

  1993cited by this paper
• Vasoconstrictive effects and SSRIs.

  1993cited by this paper
• Increased plasma concentration of imipramine following augmentation with fluvoxamine.

  1993cited by this paper
• Suicide in Depressed Patients: Medico-legal Issues

  1993cited by this paper
• Pharmacokinetics of antidepressants: why and how they are relevant to treatment.

  1993cited by this paper
• The economic burden of depression in 1990.

  1993cited by this paper
• Pharmacodynamic and pharmacokinetic interactions of selective serotonin re-uptake inhibiting antidepressants (SSRIs) with other psychotropic drugs

  1993cited by this paper
• Transmission of Helicobacter pylori via faeces.

  1993cited by this paper
• Sertraline in the treatment of bulimia nervosa.

  1993cited by this paper
• Comparative pharmacology of selective serotonin re-uptake inhibitors (SSRIs)

  1993cited by this paper
• Increased plasma concentration of imipramine following augmentation with fluvoxamine.

  1993cited by this paper
• Double‐blind study of the efficacy and safety of sertraline versus fluoxetine in major depression

  1993cited by this paper
• Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression

  1993cited by this paper
• Possible Interaction between Fluoxetine and Pimozide Causing Sinus Bradycardia

  1993cited by this paper
• Antidepressant maintenance medications: when to discontinue and how to stop.

  1993cited by this paper
• Fluvoxamine is a potent inhibitor of cytochrome P4501A2.

  1993cited by this paper
• Fluoxetine-induced sexual dysfunction and yohimbine.

  1993cited by this paper
• A double‐blind, comparative, multicentre study comparing paroxetine with fluoxetine in depressed patients

  1993cited by this paper
• Recent pharmacologic advances in antidepressant therapy for the elderly.

  1993cited by this paper
• Current issues in the pharmacologic management of obsessive compulsive disorder.

  1993cited by this paper
• An interaction between carbamazepine and fluvoxamine.

  1993cited by this paper
• Clinical Pharmacokinetics of Selective Serotonin Reuptake Inhibitors

  1993cited by this paper
• Detectable levels of fluoxetine metabolites after discontinuation: an unexpected serotonin syndrome.

  1993cited by this paper
• Citalopram: Interaction Studies with Levomepromazine, Imipramine, and Lithium

  1993cited by this paper
• Clinical pharmacokinetics of citalopram and other selective serotonergic reuptake inhibitors (SSRI).

  1992cited by this paper
• Potential Indications for the Selective Serotonin Reuptake Inhibitors

  1992cited by this paper
• Selective serotonin re-uptake inhibitors: use in depression

  1992cited by this paper
• Clinical Implications of the Pharmacology of Serotonin Reuptake Inhibitors

  1992cited by this paper
• Fluoxetine, akathisia, and suicidality: is there a causal connection?

  1992cited by this paper
• ARE PATIENTS WHO ARE INTOLERANT TO ONE SSRI, INTOLERANT TO ANOTHER?

  1992cited by this paper
• Safety of fluoxetine: Comparison with fluvoxamine

  1992cited by this paper
• Sertraline in the Prevention of Depression

  1992cited by this paper
• Fluoxetine in Elderly Patients: Is There Cause for Concern?

  1992cited by this paper
• [Pharmacotoxic psychosis and extrapyramidal motor syndrome. A case of acute adverse effect of fluoxetine and flupenthixol].

  1992cited by this paper
• Recognition and management of depression in general practice: consensus statement.

  1992cited by this paper
• Citalopram 20 mg, Citalo ram 40 mg and Placebo in the Prevention of Relapse of Major Depression

  1992cited by this paper
• Fluoxetine impairs clearance of alprazolam but not of clonazepam

  1992cited by this paper
• Fluoxetine in the treatment of bulimia nervosa. A multicenter, placebo-controlled, double-blind trial. Fluoxetine Bulimia Nervosa Collaborative Study Group.

  1992cited by this paper
• Interaction Between Fluvoxamine and Imipramine/Desipramine in Four Patients

  1992cited by this paper
• Impulsive aggression and central serotonergic system function in humans: an example of a dimensional brain‐behavior relationship

  1992cited by this paper
• Fluvoxamine improves negative symptoms in treated chronic schizophrenia: an add-on double-blind, placebo-controlled study.

  1992cited by this paper
• Suicide and fatal antidepressant poisoning.

  1992cited by this paper
• PHARMACOGENETICS OF TRICYCLIC AND NOVEL ANTIDEPRESSANTS: RECENT DEVELOPMENTS

  1992cited by this paper
• Fluoxetine-induced sexual dysfunction and an open trial of yohimbine.

  1992cited by this paper

• Differential Effects of Acute and Chronic Fluoxetine on Psychedelic-Induced Behavior in Mice: Implications for Clinical Trials

  2026cites this paper
• The Use of Antidepressants in Patients With Depression Is Associated With Gastroesophageal Reflux Disease and Disease Severity

  2025cites this paper
• β-Cyclodextrin/Zn–Fe layered double hydroxides/graphitic carbon nitride nanomaterials based potentiometric sensor for paroxetine determination in environmental water samples

  2024cites this paper
• Dose-response effects of selective serotonin reuptake inhibitor monotherapy for the treatment of depression: systematic review of reviews and meta-narrative synthesis

  2022cites this paper
• NMDA receptors as therapeutic targets for depression treatment: Evidence from clinical to basic research.

  2022cites this paper
• Right frontal anxiolytic-sensitive EEG ‘theta’ rhythm in the stop-signal task is a theory-based anxiety disorder biomarker

  2021cites this paper
• Comparative efficacy and acceptability of antidepressants and benzodiazepines for the treatment of panic disorder: A systematic review and network meta-analysis.

  2021cites this paper
• Happy Pills? Mental Health Effects of the Dramatic Increase of Antidepressant Use

  2020influential citation
• Evaluating Behavioral and Linguistic Changes During Drug Treatment for Depression Using Tweets in Spanish: Pairwise Comparison Study

  2020cites this paper
• Sleep Medicine and Mental Health: A Guide for Psychiatrists and Other Healthcare Professionals

  2020cites this paper
• Clinical Guideline

  2020cites this paper
• The Overlap Between Sleep Disorders and Psychiatric Disorders

  2020cites this paper
• The effect of local growth in antidepressant consumption on mental health outcomes

  2019cites this paper
• Preliminary Study on the Preventive Effect of Ginsenoside Rg1 on Posttraumatic Stress Disorder in Mice

  2019cites this paper
• Simultaneous determination of citalopram, paroxetine, fluoxetine, and sertraline by high-temperature liquid chromatography

  2018cites this paper
• Evaluation of the pharmacokinetics of ketamine for the treatment of major depressive disorder.

  2018influential citation
• Improvement of Outcome in Patients with Depression: Positive Emotion and Recovery of Interest

  2018cites this paper
• Pharmacodynamics of Serotonin. Emphasis on 5HT-3 Antagonists and SSRI Medication (II)

  2016cites this paper
• A discourse analysis of psychotherapists’ account of their work with people who are taking prescribed anti-depressant medication.

  2015cites this paper
• A comparative study of solid and liquid inner contact paroxetine hydrochloride ion-selective electrode membranes

  2015cites this paper
• The impact of stress on glia: a characterisation of the chronic stress-induced density and morphological alterations observed in astrocytes and microglia

  2014cites this paper
• Construction and Performance Characterization of Ion‐Selective Electrodes for Potentiometric Determination of Paroxetine Hydrochloride in Pharmaceutical Preparations and Biological Fluids

  2014cites this paper
• Determination of selective serotonin reuptake inhibitors in plasma and urine by micellar liquid chromatography coupled to fluorescence detection.

  2014cites this paper
• Out-of-Hospital Medication Errors Among Young Children in the United States, 2002–2012

  2014cites this paper
• Cardiovascular, metabolic, endocrine and behavioral aspects of development in postnatal lambs in relation to age, sex, lamb number and acute fluoxetine administration

  2013influential citation
• Paroxetine

  2012cites this paper
• Outpatient utilization of psychopharmaceuticals: comparison between the cities of Zagreb and Sarajevo (2006-2009).

  2012cites this paper
• Decreased Aggressive and Locomotor Behaviors in Betta Splendens after Exposure to Fluoxetine

  2012cites this paper
• Running Head : SSRI-INDUCED SEXUAL DYSFUNTION 1 Assessing , Diagnosing , and Treating SSRI-Induced Sexual Dysfunction

  2011cites this paper
• Chapter 7 Antidepressants and antipsychotics

  2008cites this paper
• Effect of different challenge doses after repeated citalopram treatment on extracellular serotonin level in the medial prefrontal cortex: In vivo microdialysis study

  2008cites this paper
• In vitro metabolism of CP-122,721 ((2S,3S)-2-phenyl-3-[(5-trifluoromethoxy-2-methoxy)benzylamino]piperidine), a non-peptide antagonist of the substance P receptor.

  2007cites this paper
• 5-HT1A receptor agonist affects fear conditioning through stimulations of the postsynaptic 5-HT1A receptors in the hippocampus and amygdala.

  2006cites this paper
• Long-term effects of fluoxetine or vehicle administration during pregnancy on behavioral outcomes in guinea pig offspring

  2005cites this paper
• The Stigma of Mental Illness in Germany: A Trend Analysis

  2005cites this paper
• Have there been any changes in the public's attitudes towards psychiatric treatment? Results from representative population surveys in Germany in the years 1990 and 2001

  2005cites this paper
• Supporting tools in psychiatric treatment decision-making: sertraline outcome investigation with artificial neural network method.

  2005cites this paper
• Discriminative stimulus properties of tianeptine

  2005cites this paper
• Stress and Prefrontal Cortical Dysfunction in the Rat

  2004cites this paper
• Influence of mirtazapine on the sexual behavior of male rats

  2004cites this paper
• Effects of fluoxetine on dopamine D2 receptors in the human brain: a positron emission tomography study with [11C]raclopride.

  2004cites this paper
• Effects of fluoxetine on dopamine D 2 receptors in the human brain: a positron emission tomography study with [ 11 C]raclopride

  2004cites this paper
• Public Attitudes Towards Psychotropic Drugs: Have there been any Changes in Recent Years?

  2004cites this paper
• Fluvoxamine versus fluoxetine in major depressive episode: a double‐blind randomised comparison

  2003cites this paper
• Determination of paroxetine in geriatric depression by high-performance liquid chromatography.

  2003cites this paper
• Saiko-ka-ryukotsu-borei-to, a herbal medicine, ameliorates chronic stress-induced depressive state in rotarod performance.

  2003cites this paper
• Changes in synaptic properties in cortical-limbic communications induced by repeated treatments with fluvoxamine in rats.

  2003cites this paper
• Paroxetine: an update of its use in psychiatric disorders in adults.

  2002cites this paper
• Paroxetineof Its Use in Psychiatric Disorders in Adults

  2002cites this paper
• Serotonin-selektive Antidepressiva(SSRI, DSA)

  2002cites this paper
• Anksiozna stanja i antidepresivi Anxiety States and Antidepressives

  2002cites this paper
• Measurement of Michaelis constants for cytochrome P450-mediated biotransformation reactions using a substrate depletion approach.

  2002cites this paper
• Simultaneous determination of citalopram, fluoxetine, paroxetine and their metabolites in plasma by temperature-programmed packed capillary liquid chromatography with on-column focusing of large injection volumes.

  2002cites this paper
• Clinical outcome and tolerability of sertraline in major depression: a study with plasma levels.

  2002cites this paper
• Separation of five recently commercialized selective serotonin reuptake inhibitor antidepressants by capillary electrophoresis

  2002cites this paper
• Chronic stress impairs rotarod performance in rats: implications for depressive state.

  2002cites this paper
• Drug Interactions between Psychoactive Agents and Antiepileptic Agents.

  2001cites this paper
• Effect of chronic administration of flesinoxan and fluvoxamine on freezing behavior induced by conditioned fear.

  2001cites this paper
• Unmet needs in the pharmacological management of depression

  2001cites this paper
• Long-term treatment with citalopram in patients with highly recurrent forms of unipolar depression.

  2001cites this paper
• The effect of selective serotonin reuptake inhibitors (SSRIs) on the pharmacokinetics and metabolism of perazine in the rat

  2001cites this paper
• Antidepressants and the biology of depression

  2001cites this paper
• Reply to J. L. Palmer — Postoperative delirium indicating an adverse drug interaction involving the selective serotonin reuptake inhibitor, paroxetine?

  2000cites this paper
• Fluvoxamine. An updated review of its use in the management of adults with anxiety disorders.

  2000influential citation
• THE ROLE OF FOLIC ACID IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER

  2000cites this paper
• Effects of RO 60 0175, a 5-HT(2C) receptor agonist, in three animal models of anxiety.

  2000cites this paper
• 5‐HT1A and beyond: the role of serotonin and its receptors in depression and the antidepressant response

  2000cites this paper
• Regulation of Central Corticosteroid Receptors Following Short‐Term Activation of Serotonin Transmission by 5‐Hydroxy‐ L‐Tryptophan or Fluoxetine

  2000cites this paper
• Selegiline-citalopram combination in patients with Parkinson's disease and major depression

  2000cites this paper
• Aktuelle Aspekte der psychopharmakotherapeutischen Depressionsbehandlung

  2000cites this paper
• Selegiline-citalopram combination in patients with Parkinson's disease and major depression

  2000cites this paper
• Chapter 23 Antidepressant and anxiolytic drugs

  2000cites this paper
• Feeding and reward interactions from chronic paroxetine treatment.

  1999cites this paper
• New Drug Treatments in Psychiatric Disease

  1999cites this paper
• Long term efficacy of paroxetine in major depression: A study with plasma levels.

  1999cites this paper
• Postoperative delirium indicating an adverse drug interaction involving the selective serotonin reuptake inhibitor, paroxetine?

  1999cites this paper
• A comparison of the effects of different serotonin reuptake blockers on sexual behaviour of the male rat.

  1999cites this paper
• Effect of subchronic lithium carbonate treatment on anxiolytic-like effect of citalopram and MKC-242 in conditioned fear stress in the rat.

  1999cites this paper
• The discriminative stimulus properties of LY233708, a selective serotonin reuptake inhibitor, in the pigeon

  1999cites this paper
• Systematic Review and Guide to Selection of Selective Serotonin Reuptake Inhibitors

  1999cites this paper
• The Norwegian naturalistic treatment study of depression in general practice (NORDEP)—I: randomised double blind study

  1999cites this paper
• Effects of repeated fluoxetine on anxiety-related behaviours, central serotonergic systems, and the corticotropic axis axis in SHR and WKY rats.

  1999cites this paper
• Genetic polymorphisms of human N-acetyltransferase, cytochrome P450, glutathione-S-transferase, and epoxide hydrolase enzymes: relevance to xenobiotic metabolism and toxicity.

  1999cites this paper
• Simultaneous determination of citalopram, fluoxetine, paroxetine and their metabolites in plasma and whole blood by high-performance liquid chromatography with ultraviolet and fluorescence detection.

  1999cites this paper
• Simultaneous determination of human plasma levels of citalopram, paroxetine, sertraline, and their metabolites by gas chromatography-mass spectrometry.

  1998cites this paper
• Familial concordance of fluvoxamine response as a tool for differentiating mood disorder pedigrees.

  1998cites this paper
• Effects of fluvoxamine and citalopram in maintaining abstinence in a sample of Italian detoxified alcoholics.

  1998cites this paper
• SSRI-Induced extrapyramidal side-effects and akathisia: implications for treatment

  1998cites this paper
• Stimulus properties of fluvoxamine in a conditioned taste aversion procedure

  1998cites this paper
• Milnacipran, a new specific serotonin and noradrenaline reuptake inhibitor.

  1998cites this paper
• The Role of Antidepressants in the Elderly

  1998cites this paper
• Fluoxetineic Review of its Use in Depression

  1998cites this paper
• Serotonin syndrome following SSRI mono‐therapy

  1998cites this paper
• Fluoxetine. A pharmacoeconomic review of its use in depression.

  1998influential citation
• Selective Serotonin Reuptake Inhibitors

  1997cites this paper
• Fluvoxamine and fluoxetine do not interact in the same way with the metabolism of the enantiomers of methadone.

  1997cites this paper
• Die Psychopharmakotherapie der schweren Depression unter klinischen Bedingungen

  1997cites this paper
• Effects of the co-administration of 5-HT1A receptor antagonists with an SSRI in conditioned fear stress-induced freezing behavior.

  1997cites this paper
• Clinically Relevant Pharmacology of Selective Serotonin Reuptake Inhibitors

  1997cites this paper
• Selektive Serotonin-Wiederaufnahmehemmer (SSRI) bei therapieresistenten und schweren Depressionen

  1997cites this paper